Alembic Pharmaceuticals has registered 31.67% rise in its net profit at Rs 84.05 crore for the quarter under review as compared to Rs 63.83 crore for the same quarter in the previous year. However, total income of the company has increased 11.54% at Rs 541.52 crore for Q2FY15 as compared Rs 485.46 crore for the corresponding quarter previous year.
On consolidated basis, the company’s net profit after taxes and minority interest for the quarter under review registered 23.35% growth at Rs 77.27 crore against Rs 61.64 crore in the September quarter of previous fiscal. The company’s total income has increased by 12.46% at Rs 547.22 crore for the quarter under review from Rs 486.56 crore in the similar quarter of previous year.Real Time News & Trading Trends Keep Liking Epic Research Private Limited
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co
No comments:
Post a Comment